Linde Q3 2026: Restructuring Charge, Electronics Growth, and $8B Backlog—But Valuation Still Stretched

What happened

Linde recorded a $425 million restructuring charge in Q3 2026, signaling management's push to cut costs as the company confronts flat volumes and helium/rare-gas pricing pressure. Electronics sales grew 15% year-over-year, driven by strong demand in Asia and the U.S., which partially offsets weakness in industrial end-markets like metals and chemicals. The company reiterated an $8 billion sales backlog for gas projects, which provides visibility but is only a fraction of the $62 billion in remaining performance obligations, much of which is long-dated. The restructuring charge, while expected to yield benefits in 2H 2026, adds near-term noise to earnings and does little to change the core challenge: a premium valuation at 33x forward earnings with limited room for execution missteps. Overall, the update reinforces the WAIT rating—the electronics strength and backlog are positive, but helium headwinds persist and the stock's risk-reward remains unattractive unless startup cadence accelerates or the price pulls back.

Implication

The $425 million restructuring charge confirms management is actively addressing cost inefficiencies, but the benefits are not yet visible in margins and may take until 2H 2026 to materialize, adding uncertainty to near-term earnings. The 15% electronics growth is a clear bright spot, reflecting Linde's ability to capture demand from semiconductors and space, but this segment alone is unlikely to offset the drag from soft industrial volumes and helium pricing across APAC and Other. The $8 billion project backlog is supportive of medium-term revenue, but investors should recognize that conversion to revenue is back-end loaded and subject to execution risk, as evidenced by the company's recent startup delays. At $496.51 and 33x forward earnings, the market is already pricing in a successful execution of the 2026 startup plan and a fade in helium headwinds, leaving little margin of safety if either assumption staggers. Therefore, we maintain our WAIT rating and would look to add on a pullback to $450, while a sustained close above $560 on confirmed margin expansion would warrant a reassessment.

Thesis delta

While the Q3 2026 update provides incremental positives (electronics growth, sizable backlog), it also includes a $425 million restructuring charge that underscores near-term cost pressure. The core thesis that Linde is a resilient compounder with execution risk remains intact, but the evidence of restructuring and electronics strength slightly improves the odds of meeting 2026 EPS guidance. We keep our WAIT rating, as valuation still leaves little room for error.